![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Siegfried Ag Zofingen Ch, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Morphine hemisulfate 2.5-hydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2005-211 - Rev 02
This Chemical Type CEP, issued on May 13, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1244 associated with this CEP further emphasizes